EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

AI across the RNA therapeutics lifecycle: discovery, development, and the road to personalized medicine

Edward Miracco

Nucleic Acid Insights · 12.11.2026 · 3 (9) · 637–643

DOI: 10.18609/nai.2026.084 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acid Insights, online erschienen am 12.11.2026. Verfasst von Edward Miracco. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Jokūbas Leikauskas, Editor, Nucleic Acid Insights, speaks with Edward Miracco, Head of Enterprise AI Enablement, Moderna, about enterprise AI adoption, AI-driven lipid nanoparticle and neoantigen design, rare disease applications of mRNA, and the future of RNA therapeutics.

Zitieren

APA

Miracco, E. (2026). AI across the RNA therapeutics lifecycle: discovery, development, and the road to personalized medicine. Nucleic Acid Insights, 3(9), 637–643. https://doi.org/10.18609/nai.2026.084

Vancouver

Miracco E. AI across the RNA therapeutics lifecycle: discovery, development, and the road to personalized medicine. Nucleic Acid Insights. 2026;3(9):637–643. doi:10.18609/nai.2026.084

BibTeX
@article{Miracco2026,
  author = {Miracco, Edward},
  title = {AI across the RNA therapeutics lifecycle: discovery, development, and the road to personalized medicine},
  journal = {Nucleic Acid Insights},
  year = {2026},
  volume = {3},
  number = {9},
  pages = {637–643},
  doi = {10.18609/nai.2026.084}
}
Kostenlos starten →